Eternity Hlthcre (ETAH) 0.1000 $ETAH
Eternity Healthcare, Inc. and Shanghai Yin Jun Investment & Development, Inc. Establish a Joint Venture Operation for US$3 Million Dollars
GlobeNewswire - Wed Jul 23, 7:26AM CDT
Eternity Healthcare Inc. (OTCBB:ETAH), a medical device and diagnostic company, announced today that it has signed an agreement with Shanghai Yin Jun Investment & Development Inc., to establish a Joint Venture manufacturing operation in China.
Eternity Healthcare to Initiate a Large Scale Clinical Trial of Its Needle-Free Injection System in Patients Undergoing Fertility Treatments Using the Drug Gonadotropins
Business Wire - Mon Mar 17, 7:25AM CDT
Eternity Healthcare Inc. (OTCBB: ETAH), a medical device and diagnostic company, announced today that they have signed an agreement with a major fertility clinic, Pacific Center for Reproductive Medicine. Eternity Healthcare and Pacific Center for Reproductive Medicine (PCRM) will partner for a large clinical trial that will use the Comfort-in(TM) Needle-Free Injection System in PCRM patients undergoing fertility treatments using the drug Gonadotropins.
Eternity Healthcare Terminates Letter of Intent (LOI) With Global Medical Equipment of America (GMEA)
GlobeNewswire - Fri Feb 28, 5:30AM CST
Eternity Healthcare Inc. (OTCBB:ETAH), or the "Company", a medical device and diagnostic company, announced today that it has terminated the Letter of Intent (LOI) agreement with Phoenix-based Global Medical Equipment of America (GMEA). The Letter of Intent was written to acquire 100% of the company through a share exchange.
Eternity Healthcare Announces $500,000 Regulation S Private Placement for Development of a Dual Sensor Noninvasive Saliva-Based Sugar Monitor Device to Test for Diabetes
GlobeNewswire - Mon Feb 24, 10:51AM CST
Eternity Healthcare (OTCBB:ETAH) or the "Company" a Medical Device and Diagnostic company today announced to sell 800,000 Common Stock for the total proceed of $500,000.00 USD exempt for registration under the Securities and Exchange under the Regulation S. The shares will be issued to international investor's and will be restricted under 144 rules for reselling. The Company plans to close the financing within 45 days, unless extended by mutual agreement. The proceeds from this financing will be used to finance the research and development of current products and products in the pipeline.
Eternity Healthcare to Develop a Dual Sensor Noninvasive Saliva-Based Sugar Monitor Device to Test for Diabetes
Business Wire - Tue Feb 11, 7:06AM CST
Eternity Healthcare Inc. (OTCBB:ETAH), a medical device and diagnostic company specializing in diabetes management, announced today that they are in development of a noninvasive sugar monitoring device using saliva instead of blood. The technology utilizes an ultra sensitive sugar monitor and an additional sensor for salivary amylase enzyme activity.
Eternity Healthcare to Develop a Noninvasive Saliva-Based Sugar Monitor Device to Test for Diabetes
GlobeNewswire - Tue Feb 04, 9:48PM CST
Eternity Healthcare Inc. (OTCBB:ETAH), a leading medical device and diagnostic company with special focus on diabetes management, announced today that they are in development of a noninvasive sugar monitoring device using saliva instead of blood.
OtcbbJournal.com Initiates Coverage on ETAH, CSBR, AIVN and MTPR
Marketwire - Tue Sep 03, 7:01AM CDT
Eternity Healthcare, Inc. (OTCQB: ETAH) is a biopharmaceutical company with technologies in drug delivery, specialty pharmaceuticals and medical devices, currently focusing on the development of new subcutaneous formulation of otherwise intramuscular injectable drugs and needle-free injection systems. If you don't like needles, you need to see this report: http://bit.ly/ETAHREPORT
Eternity Healthcare Announces Financing Completed in the Amount of $1.3 Million U.S. Dollars
Marketwire - Thu Aug 29, 7:26AM CDT
Eternity Healthcare Inc. (OTCQB: ETAH), or the "Company," a biopharmaceutical company with technologies in drug delivery, specialty pharmaceuticals and medical devices, announced today that it has completed a financing in the amount of $1,362,434 for issuance of 2,724,868 Common Shares to international investors. The Company sold restricted Common Shares at a price of $0.50 per share under Regulation S which are subject to rule 144. The Common Shares issued are restricted for resale until either a registration statement is filed with the Security and Exchange Commission or the time period for registration expires under rule 144 and restriction legends are removed.
Eternity Healthcare Completes Financing of $1.3 million for Business Development
ACCESSWIRE - Tue Aug 27, 7:33AM CDT
Vancouver, BC, and Phoenix, AZ, August 27 , 2013 - (Accesswire) - Eternity Healthcare Inc. (OTCQB: ETAH), or the "Company," a biopharmaceutical company with technologies in drug delivery, specialty pharmaceuticals and medical devices, announced today that it has completed a financing in the amount of $1,362,434 for issuance of 2,724,868 Common Shares to international investors. The Company sold restricted Common Shares at a price of $0.50 per share under Regulation S which are subject to rule 144. The Common Shares issued are restricted for resale until either a registration statement is filed with the Security and Exchange Commission or the time period for registration expires under rule 144 and restriction legends are removed.
Eternity Healthcare and PharmaNova Sign Letter of Intent to Develop New Branded Pharmaceuticals
GlobeNewswire - Mon Jul 15, 7:41AM CDT
Eternity Healthcare, Inc. (OTC:ETAH), or 'Eternity', a medical device company, announced today that it has signed a letter of Intent with PharmaNova Inc. of New York to develop a new generation of steroids and steroids related pharmaceuticals for rapid subcutaneous absorption. The companies will utilize PharmaNova's NovaSperse nanoparticle technology to enhance the aqueous dissolution of lipid soluble drugs enabling them to be administered using Eternity Healthcare's - Comfort-In(TM) needle-free injection system.
Eternity Healthcare, Inc. Signs Sponsorship Agreement With Native American Professional Golfer Alexandrea Schulte, as Spokesperson at the NIGA Indian Gaming Tradeshow and Convention March 25-27 in Phoenix, Arizona
GlobeNewswire - Mon Mar 25, 7:18AM CDT
Eternity Healthcare, Inc. or the "Company" (OTC: ETAH), announced today they have entered into a sponsorship agreement with Alexandrea Schulte ("Alex"
for corporate representation at The National Indian Gaming Association's (NIGA) Indian Gaming Tradeshow and Convention which is the nation's premier Indian gaming event where Indian gaming executives, buyers, and industry professionals meet each spring to conduct major business.
Eternity Healthcare, Inc. Signs Agreement With Native American Marketing Enterprises, Inc. to Present the Comfort-in(TM) to the Native American Tribal Community
GlobeNewswire - Tue Mar 12, 7:37AM CDT
Eternity Healthcare, Inc. (OTC:ETAH), or the Company, a medical device company, announced today that it has signed an agreement with Native American Marketing Enterprises, Inc. (NAME), which provides introductions to Native American Tribal Communities. NAME will be introducing Eternity Healthcare's Comfort-in(TM) needle-less, pain-free injection system designed for children and adults adapted to use by diabetes insulin patients and any patients who need multiple injections to the Indian Health Service, Native American Health Organizations and tribal councils throughout the United States and Canada.
Eternity Healthcare to Present at 15th Annual BIO CEO & Investor Conference
Marketwire - Thu Feb 07, 8:31AM CST
Eternity Healthcare (the "Company" (OTCBB: ETAH) announced that Dr. Hassan Salari, President & CEO will be presenting at the 15th Annual BIO CEO & Investor Conference. Hosted by the Biotechnology Industry Organization (BIO), the 15th Annual BIO CEO & Investor Conference will take place February 11-12 at the Waldorf-Astoria in New York City. Eternity Healthcare will be presenting to the attendees from industry, financial and social media sectors. The presentation will be webcast at the followings, on Monday February 11 at 3:30. The URL for webcast is: http://www.veracast.com/webcasts/bio/ceoinves...122224.cfm
Eternity Healthcare, Inc. and Shanghai Yin Jun Investment & Development, Inc. Establish a Joint Venture Operation for US$3 Million Dollars
GlobeNewswire - Wed Jul 23, 7:26AM CDT
Eternity Healthcare Inc. (OTCBB:ETAH), a medical device and diagnostic company, announced today that it has signed an agreement with Shanghai Yin Jun Investment & Development Inc., to establish a Joint Venture manufacturing operation in China.
Eternity Healthcare to Initiate a Large Scale Clinical Trial of Its Needle-Free Injection System in Patients Undergoing Fertility Treatments Using the Drug Gonadotropins
Business Wire - Mon Mar 17, 7:25AM CDT
Eternity Healthcare Inc. (OTCBB: ETAH), a medical device and diagnostic company, announced today that they have signed an agreement with a major fertility clinic, Pacific Center for Reproductive Medicine. Eternity Healthcare and Pacific Center for Reproductive Medicine (PCRM) will partner for a large clinical trial that will use the Comfort-in(TM) Needle-Free Injection System in PCRM patients undergoing fertility treatments using the drug Gonadotropins.
Eternity Healthcare Terminates Letter of Intent (LOI) With Global Medical Equipment of America (GMEA)
GlobeNewswire - Fri Feb 28, 5:30AM CST
Eternity Healthcare Inc. (OTCBB:ETAH), or the "Company", a medical device and diagnostic company, announced today that it has terminated the Letter of Intent (LOI) agreement with Phoenix-based Global Medical Equipment of America (GMEA). The Letter of Intent was written to acquire 100% of the company through a share exchange.
Eternity Healthcare Announces $500,000 Regulation S Private Placement for Development of a Dual Sensor Noninvasive Saliva-Based Sugar Monitor Device to Test for Diabetes
GlobeNewswire - Mon Feb 24, 10:51AM CST
Eternity Healthcare (OTCBB:ETAH) or the "Company" a Medical Device and Diagnostic company today announced to sell 800,000 Common Stock for the total proceed of $500,000.00 USD exempt for registration under the Securities and Exchange under the Regulation S. The shares will be issued to international investor's and will be restricted under 144 rules for reselling. The Company plans to close the financing within 45 days, unless extended by mutual agreement. The proceeds from this financing will be used to finance the research and development of current products and products in the pipeline.
Eternity Healthcare to Develop a Dual Sensor Noninvasive Saliva-Based Sugar Monitor Device to Test for Diabetes
Business Wire - Tue Feb 11, 7:06AM CST
Eternity Healthcare Inc. (OTCBB:ETAH), a medical device and diagnostic company specializing in diabetes management, announced today that they are in development of a noninvasive sugar monitoring device using saliva instead of blood. The technology utilizes an ultra sensitive sugar monitor and an additional sensor for salivary amylase enzyme activity.
Eternity Healthcare to Develop a Noninvasive Saliva-Based Sugar Monitor Device to Test for Diabetes
GlobeNewswire - Tue Feb 04, 9:48PM CST
Eternity Healthcare Inc. (OTCBB:ETAH), a leading medical device and diagnostic company with special focus on diabetes management, announced today that they are in development of a noninvasive sugar monitoring device using saliva instead of blood.
OtcbbJournal.com Initiates Coverage on ETAH, CSBR, AIVN and MTPR
Marketwire - Tue Sep 03, 7:01AM CDT
Eternity Healthcare, Inc. (OTCQB: ETAH) is a biopharmaceutical company with technologies in drug delivery, specialty pharmaceuticals and medical devices, currently focusing on the development of new subcutaneous formulation of otherwise intramuscular injectable drugs and needle-free injection systems. If you don't like needles, you need to see this report: http://bit.ly/ETAHREPORT
Eternity Healthcare Announces Financing Completed in the Amount of $1.3 Million U.S. Dollars
Marketwire - Thu Aug 29, 7:26AM CDT
Eternity Healthcare Inc. (OTCQB: ETAH), or the "Company," a biopharmaceutical company with technologies in drug delivery, specialty pharmaceuticals and medical devices, announced today that it has completed a financing in the amount of $1,362,434 for issuance of 2,724,868 Common Shares to international investors. The Company sold restricted Common Shares at a price of $0.50 per share under Regulation S which are subject to rule 144. The Common Shares issued are restricted for resale until either a registration statement is filed with the Security and Exchange Commission or the time period for registration expires under rule 144 and restriction legends are removed.
Eternity Healthcare Completes Financing of $1.3 million for Business Development
ACCESSWIRE - Tue Aug 27, 7:33AM CDT
Vancouver, BC, and Phoenix, AZ, August 27 , 2013 - (Accesswire) - Eternity Healthcare Inc. (OTCQB: ETAH), or the "Company," a biopharmaceutical company with technologies in drug delivery, specialty pharmaceuticals and medical devices, announced today that it has completed a financing in the amount of $1,362,434 for issuance of 2,724,868 Common Shares to international investors. The Company sold restricted Common Shares at a price of $0.50 per share under Regulation S which are subject to rule 144. The Common Shares issued are restricted for resale until either a registration statement is filed with the Security and Exchange Commission or the time period for registration expires under rule 144 and restriction legends are removed.
Eternity Healthcare and PharmaNova Sign Letter of Intent to Develop New Branded Pharmaceuticals
GlobeNewswire - Mon Jul 15, 7:41AM CDT
Eternity Healthcare, Inc. (OTC:ETAH), or 'Eternity', a medical device company, announced today that it has signed a letter of Intent with PharmaNova Inc. of New York to develop a new generation of steroids and steroids related pharmaceuticals for rapid subcutaneous absorption. The companies will utilize PharmaNova's NovaSperse nanoparticle technology to enhance the aqueous dissolution of lipid soluble drugs enabling them to be administered using Eternity Healthcare's - Comfort-In(TM) needle-free injection system.
Eternity Healthcare, Inc. Signs Sponsorship Agreement With Native American Professional Golfer Alexandrea Schulte, as Spokesperson at the NIGA Indian Gaming Tradeshow and Convention March 25-27 in Phoenix, Arizona
GlobeNewswire - Mon Mar 25, 7:18AM CDT
Eternity Healthcare, Inc. or the "Company" (OTC: ETAH), announced today they have entered into a sponsorship agreement with Alexandrea Schulte ("Alex"
for corporate representation at The National Indian Gaming Association's (NIGA) Indian Gaming Tradeshow and Convention which is the nation's premier Indian gaming event where Indian gaming executives, buyers, and industry professionals meet each spring to conduct major business. Eternity Healthcare, Inc. Signs Agreement With Native American Marketing Enterprises, Inc. to Present the Comfort-in(TM) to the Native American Tribal Community
GlobeNewswire - Tue Mar 12, 7:37AM CDT
Eternity Healthcare, Inc. (OTC:ETAH), or the Company, a medical device company, announced today that it has signed an agreement with Native American Marketing Enterprises, Inc. (NAME), which provides introductions to Native American Tribal Communities. NAME will be introducing Eternity Healthcare's Comfort-in(TM) needle-less, pain-free injection system designed for children and adults adapted to use by diabetes insulin patients and any patients who need multiple injections to the Indian Health Service, Native American Health Organizations and tribal councils throughout the United States and Canada.
Eternity Healthcare to Present at 15th Annual BIO CEO & Investor Conference
Marketwire - Thu Feb 07, 8:31AM CST
Eternity Healthcare (the "Company"
(OTCBB: ETAH) announced that Dr. Hassan Salari, President & CEO will be presenting at the 15th Annual BIO CEO & Investor Conference. Hosted by the Biotechnology Industry Organization (BIO), the 15th Annual BIO CEO & Investor Conference will take place February 11-12 at the Waldorf-Astoria in New York City. Eternity Healthcare will be presenting to the attendees from industry, financial and social media sectors. The presentation will be webcast at the followings, on Monday February 11 at 3:30. The URL for webcast is: http://www.veracast.com/webcasts/bio/ceoinves...122224.cfm 
